Canine brain tumors

Last updated

Cancer of the nervous system is common in domestic canids, and includes primary neoplasia of the peripheral nervous system, primary neoplasia of the central nervous system and various metastatic cancers. Some of the most common of the central nervous system tumors are several types of primary (originating from brain tissue) canine brain tumors. Examples of these include: meningiomas, astrocytomas, glioblastomas, oligodendriomas, choroid plexus papillomas, and pituitary adenomas. Breeds predisposed to brain tumors include: Boxer Dog, Pug, English Bull Dog, Boston Terrier, and Golden Retrievers. [1] [2]

Contents

Common canine brain tumors

Meningiomas

Meningiomas (arising from the meninges, a neural crest-derived cell) are the most common brain tumor of dogs, accounting for 40% of all primary brain tumors. Golden Retrievers as well as other dolichocephalic (long-nosed) breeds are particularly susceptible.

Astrocytomas and glioblastomas

Astrocytomas are the most common neuroectodermal tumor of dogs. Glioblastomas are considered a subset of astrocytomas—a particularly damaging, invasive, and undifferentiated type. Canine glioblastomas are similar to glioblastomas in humans. Studies are underway to use and develop the dog as a model of this devastating disease of humans in the hope that characterizing and successfully treating these tumors in dogs may lead to improved therapies for humans afflicted with this disease. brachycephalic (short-nosed) breeds such as the boxer, pug, Boston terrier and bulldog have a marked (25 times the normal occurrence) predilection for developing primary brain tumors to include glioblastomas.

Pituitary gland adenoma

Pituitary gland tumors are very common in the canine. A productive form arising from the anterior pituitary is the primary cause of Cushing's disease of dogs. This tumor causes excessive production of cortisol from the adrenal cortex which leads to the classic signs of alopecia (hair loss), polyuria (excessive urination), polydipsia (excessive water drinking), and a pot-bellied appearance of the abdomen due to muscle break down. See picture here.

Clinical signs

Two of the most important signs a dog may have an intracranial brain tumor are seizure and unexplained behavioral changes. Seizures manifest as a 1–2 minute display of a combination of the following: loss of consciousness, lateral recumbency (dog lying on its side), paddling of the legs, tremors, and involuntary urination/defecation. Often, the only signs an absent owner may have of a pet dog that has had a seizure is unexplained soiling of the floor by a normally house-broken pet. Behavioral changes can manifest in many ways to include nervousness, barking in the corner (dementia), pacing, aggressiveness or irritation, or deviation from normal routines. "Doggy headaches" can manifest as head pressing against walls, doors, or even owners themselves. Other signs that may be encountered are ataxia (uncoordinated ambulation), circling, blindness, lethargy, and disorientation. [1]

Treatment

At this time, there is no true cure (100% remission) for brain tumors in dogs (or any species for that matter.) In practice, brain tumors are generally considered to be malignant due to the delicate and poorly regenerative nature of neurons and restriction of the brain to the finite space of the cranium which does not allow tumor growth devoid of collateral damage to brain parenchyma. Therefore, general long-term prognosis for canine brain tumors is poor. Current treatment of brain tumors revolves around four main modalities: surgery, radiation, chemotherapy, and palliative (pain relieving) care. Depending on the type, extent, and location of the cancer, any one or combination of these techniques may be employed. For instance, the first line treatment for meningiomas is surgery but may be coupled with chemotherapy in an attempt to improve survival time. Intracranial tumors (such as glioblastoma) more commonly rely on radiation therapy as surgical access to the tumor may be prohibitively dangerous. [3] Palliative care tends to include corticosteroids to help reduce swelling and edema around tumors as well as anti-convulsant medications to control seizures.

Notes and references

  1. 1 2 "Merck Veterinary Manual".
  2. Westworth DR, Dickinson PJ, Vernau W, Johnson EG, Bollen AW, Kass PH et al (2008). Choroid plexus tumors in 56 dogs (1985–2007). J Vet Intern Med 22: 1157–65.
  3. Spugnini EP, Thrall DE, Price GS, Sharp NJ, Munana K, Page RL (2000). Primary irradiation of canine intracranial masses. Vet Radiol Ultrasound 41: 377–80.

Related Research Articles

<span class="mw-page-title-main">Brain tumor</span> Neoplasm in the brain

A brain tumor occurs when abnormal cells form within the brain. There are two main types of tumors: malignant tumors and benign (non-cancerous) tumors. These can be further classified as primary tumors, which start within the brain, and secondary tumors, which most commonly have spread from tumors located outside the brain, known as brain metastasis tumors. All types of brain tumors may produce symptoms that vary depending on the size of the tumor and the part of the brain that is involved. Where symptoms exist, they may include headaches, seizures, problems with vision, vomiting and mental changes. Other symptoms may include difficulty walking, speaking, with sensations, or unconsciousness.

<span class="mw-page-title-main">Hemangiosarcoma</span> Medical condition

Hemangiosarcoma is a rapidly growing, highly invasive variety of cancer that occurs almost exclusively in dogs, and only rarely in cats, horses, mice, or humans. It is a sarcoma arising from the lining of blood vessels; that is, blood-filled channels and spaces are commonly observed microscopically. A frequent cause of death is the rupturing of this tumor, causing the patient to rapidly bleed to death.

<span class="mw-page-title-main">Oligodendroglioma</span> Medical condition

Oligodendrogliomas are a type of glioma that are believed to originate from the oligodendrocytes of the brain or from a glial precursor cell. They occur primarily in adults but are also found in children.

<span class="mw-page-title-main">Glioblastoma</span> Aggressive type of brain cancer

Glioblastoma, previously known as glioblastoma multiforme (GBM), is one of the most aggressive types of cancer that begin within the brain. Initially, signs and symptoms of glioblastoma are nonspecific. They may include headaches, personality changes, nausea, and symptoms similar to those of a stroke. Symptoms often worsen rapidly and may progress to unconsciousness.

<span class="mw-page-title-main">Astrocytoma</span> Medical condition

Astrocytomas are a type of brain tumor. They originate in a particular kind of glial cells, star-shaped brain cells in the cerebrum called astrocytes. This type of tumor does not usually spread outside the brain and spinal cord and it does not usually affect other organs. Astrocytomas are the most common glioma and can occur in most parts of the brain and occasionally in the spinal cord.

<span class="mw-page-title-main">Dog health</span> Health of dogs

The health of dogs is a well studied area in veterinary medicine.

Epilepsy in animals is a group of neurological disorders characterized by seizures, caused by abnormal bursts of electrical activity in the brain. They can start and stop very abruptly and last any amount of time from a few seconds to a few minutes. Canine epilepsy is often genetic but epilepsy in cats and other pets is rarer, likely because there is no hereditary component to epilepsy in these animals.

<span class="mw-page-title-main">Lymphoma in animals</span>

Lymphoma (lymphosarcoma) in animals is a type of cancer defined by a proliferation of malignant lymphocytes within solid organs such as the lymph nodes, bone marrow, liver and spleen. The disease also may occur in the eye, skin, and gastrointestinal tract.

Granulomatous meningoencephalitis (GME) is an inflammatory disease of the central nervous system (CNS) of dogs and, rarely, cats. It is a form of meningoencephalitis. GME is likely second only to encephalitis caused by canine distemper virus as the most common cause of inflammatory disease of the canine CNS. The disease is more common in female dogs of young and middle age. It has a rapid onset. The lesions of GME exist mainly in the white matter of the cerebrum, brainstem, cerebellum, and spinal cord. The cause is only known to be noninfectious and is considered at this time to be idiopathic. Because lesions resemble those seen in allergic meningoencephalitis, GME is thought to have an immune-mediated cause, but it is also thought that the disease may be based on an abnormal response to an infectious agent. One study searched for viral DNA from canine herpesvirus, canine adenovirus, and canine parvovirus in brain tissue from dogs with GME, necrotizing meningoencephalitis, and necrotizing leukoencephalitis, but failed to find any.

<span class="mw-page-title-main">Choroid plexus papilloma</span> Medical condition

Choroid plexus papilloma, also known as papilloma of the choroid plexus, is a rare benign neuroepithelial intraventricular WHO grade I lesion found in the choroid plexus. It leads to increased cerebrospinal fluid production, thus causing increased intracranial pressure and hydrocephalus.

<span class="mw-page-title-main">Cancer in dogs</span>

Cancer is the leading cause of death in dogs. It is estimated that 1 in 3 domestic dogs will develop cancer, which is the same incidence of cancer among humans. Dogs can develop a variety of cancers and most are very similar to those found in humans. Dogs can develop carcinomas of epithelial cells and organs, sarcomas of connective tissues and bones, and lymphomas or leukemias of the circulatory system. Selective breeding of dogs has led certain pure-bred breeds to be at high-risk for specific kinds of cancer.

Choroid plexus tumors are a rare type of cancer that occur from the brain tissue called choroid plexus of the brain. Choroid plexus tumors (CPTs) are uncommon CNS tumors that account for 0.5–0.6% of intracranial neoplasms in people of all ages. Choroid plexus papilloma (CPP), atypical choroid plexus papilloma (aCPP), and choroid plexus carcinoma (CPC) are the three WHO grades for these cancers, respectively. Children under the age of five account for 10% of CPT cases. In children and adults, respectively, the lateral ventricle and the fourth ventricle are common locations, About 5% of all CPTs are located in the third ventricle. Along with other unusual places such the cerebellopontine angle, the Luschka foramen, or brain parenchyma, the third ventricle is a rare location for CPTs. Together, aCPP and CPC make up around 25% of all CPTs. Although there have been reports of third ventricle choroid plexus papillomas in people in their fifth decade of life, only 14% of choroid plexus tumors are reported to arise in infants.Most findings indicate that CPTs have no known sex preferences.

<span class="mw-page-title-main">Choroid plexus carcinoma</span> Medical condition

A choroid plexus carcinoma is a type of choroid plexus tumor that affects the choroid plexus of the brain. It is considered the worst of the three grades of chord plexus tumors, having a much poorer prognosis than choroid atypical plexus papilloma and choroid plexus papilloma. The disease creates lesions in the brain and increases cerebrospinal fluid volume, resulting in hydrocephalus.

Hypoadrenocorticism in dogs, or, as it is known in people, Addison's disease, is an endocrine system disorder that occurs when the adrenal glands fail to produce enough hormones for normal function. The adrenal glands secrete glucocorticoids such as cortisol and mineralocorticoids such as aldosterone; when proper amounts of these are not produced, the metabolic and electrolyte balance is upset. Mineralocorticoids control the amount of potassium, sodium, and water in the body. Hypoadrenocorticism is fatal if left untreated.

<span class="mw-page-title-main">WHO classification of tumours of the central nervous system</span>

The following is a simplified (deprecated) version of the 2021 WHO classification of the tumours of the central nervous system. Currently, as of 2021, clinicians are using the WHO grade 5th edition, which incorporates recent advances in molecular pathology.

<span class="mw-page-title-main">Giant-cell glioblastoma</span>

The giant-cell glioblastoma is a histological variant of glioblastoma, presenting a prevalence of bizarre, multinucleated giant cells.

<span class="mw-page-title-main">Grading of the tumors of the central nervous system</span>

The concept of grading of the tumors of the central nervous system, agreeing for such the regulation of the "progressiveness" of these neoplasias, dates back to 1926 and was introduced by P. Bailey and H. Cushing, in the elaboration of what turned out the first systematic classification of gliomas.
In the following, the grading systems present in the current literature are introduced. Then, through a table, the more relevant are compared.

Neuro-oncology is the study of brain and spinal cord neoplasms, many of which are very dangerous and life-threatening. Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade astrocytoma/oligodendroglioma are among the worst. In these cases, untreated survival usually amounts to only a few months, and survival with current radiation and chemotherapy treatments may extend that time from around a year to a year and a half, possibly two or more, depending on the patient's condition, immune function, treatments used, and the specific type of malignant brain neoplasm. Surgery may in some cases be curative, but, as a general rule, malignant brain cancers tend to regenerate and emerge from remission easily, especially highly malignant cases. In such cases, the goal is to excise as much of the mass and as much of the tumor margin as possible without endangering vital functions or other important cognitive abilities. The Journal of Neuro-Oncology is the longest continuously published journal in the field and serves as a leading reference to those practicing in the area of neuro-oncology.

<span class="mw-page-title-main">Fibrillary astrocytoma</span> Type of brain tumor

Fibrillary astrocytomas are a group of primary slow-growing brain tumors that typically occur in adults between the ages of 20 and 50.